Close Menu

NEW YORK (360Dx) – Shares of Quest Diagnostics were down almost 10 percent on the New York Stock Exchange in early morning trading today following the company's announcement after the close of the market on Wednesday that it had lowered its full-year 2018 guidance on the top and bottom lines.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.